References
- Drey EA, Foster DG, Jackson RA, et al. Risk factors associated with presenting for abortion in the second trimester. Obstet Gynecol 2006;107:128–35
- Royal College of Obstetricians and Gynaecologists. The care of women requesting induced abortion. Guidelines No. 7. London; 2004
- Lalitkumar S, Bygdeman M, Gemzell-Danielsson K. Mid-trimester induced abortion: a review. Human Reprod Update 2007;13:37–52
- World Health Organization. Unsafe abortion: global estimates of the incidence of unsafe abortion and associated mortality in 2000. 4th ed. Geneva: WHO; 2004
- Ho PC, Ngai SW, Liu KL, et al. Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancy. Obstet Gynecol 1997;90:735–8
- Ngai SW, Tang OS, Ho PC. Randomized comparison of vaginal (200 microg every 3 h) and oral (400 microg every 3 h) misoprostol when combined with mifepristone in termination of second trimester pregnancy. Human Reprod 2000;15:2205–8
- Wong KS, Ngai CS, Yeo EL, et al. A comparison of two regimens of intravaginal misoprostol for termination of second trimester pregnancy: a randomized comparative trial. Human Reprod 2000;15:709–12
- Herabutya Y, Chanrachakul B, Punyavachira P. Vaginal misoprostol in termination of second trimester pregnancy. J Obstet Gynaecol Res 2000;26:121–5
- Herabutya Y, Chanrachakul B, Punyavachira P. Second trimester pregnancy termination: a comparison of 600 and 800 micrograms of intravaginal misoprostol. J Obstet Gynaecol Res 2001;27:125–8
- Mekbib TA. Induction of abortion by condom-Foley catheter method in pregnant women with intra-uterine foetal death. Ethiopian Med J 1994;32:107–13
- Ghorab MN, El Helw BA. Second-trimester termination of pregnancy by extra-amniotic prostaglandin F2alfa or endocervical misoprostol. A comparative study. Acta Obstet Gynecol Scand 1998;77:429–32
- Boza AV, de León RG, Castillo LS, et al. Misoprostol preferable to ethacridine lactate for abortions at 13–20 weeks of pregnancy: Cuban experience. Reprod Health Matters 2008;16:189–95
- Herabutya Y, O-Prasertsawat P. Intra-cervical prostaglandin E2 gel in management of dead fetus in utero. Asia Oceania J Obstet Gynaecol 1991;17:335–9
- Shipra K, Pradip KS, Poonam G, et al. Second trimester pregnancy termination with 400 μg vaginal misoprostol: efficacy and safety. BioSci Trends 2010;4:351–4
- Rodger MW, Baird DT. Preteatment with mifepristone (RU486) reduces interval between prostaglandin administration and expulsion in second trimester abortion. Br J Obstet Gynaecol 1990;97:41–5
- Ho PC, Ma HK. Termination of second trimester pregnancy with sulprostone and mifepristone: a randomized double-blind placebo-controlled trial. Contraception 1993;47:123–9
- Jain JK, Mishell DR Jr. A comparison of misoprostol with and without laminaria tents for induction of second-trimester abortion. Am J Obstet Gynecol 1996;175:173–7
- Ashok PW, Templeton A, Wagaarachchi PT, Flett GM. Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases. Contraception 2004;69:51–8
- Hamoda H, Ashok PW, Flett GM, Templeton A. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13–20 weeks gestation. Hum Reprod 2005;20:2348–54
- Ashok PW, Templeton AA. Non surgical mid-trimester termination of pregnancy: a review of 500 consecutive cases. Br J Obstet Gynaecol 1999;106:706–10
- Tang OS, Thong KJ, Baird DT. Second trimester medical abortion with mifepristone and gemeprost: a review of 956 cases. Contraception 2001;64:29–32
- Yapar EG, Senoz S, Urkutur M, et al. Second trimester pregnancy termination including fetal death: comparison of five different methods. Eur J Obstet Gynecol Reprod Biol 1996;69:97–102